Lyra Therapeutics Inc
LYRA29.010USD
+24.080+488.44%
交易中 （美东）报价延迟15分钟
1.91B总市值
亏损市盈率 TTM
关于 Lyra Therapeutics Inc 公司
Lyra Therapeutics, Inc. 是一家临床阶段的生物技术公司。该公司专注于开发和商业化用于局部治疗慢性鼻窦炎 (CRS) 患者的疗法。该公司有两种研究性候选产品 LYR-210 和 LYR-220，正处于针对 CRS 的后期开发阶段，CRS 是一种常见的鼻旁窦炎症性疾病，会导致衰弱症状和严重发病率。LYR-210 和 LYR-220 是生物可吸收的鼻植入物，旨在通过简单的诊室手术进行给药，旨在为鼻腔通道提供六个月的持续糠酸莫米松药物治疗。 LYR-210 专为未接受过手术的患者设计，目前正在 ENLIGHTEN 第三期临床项目中进行评估，而 LYR-220 正在 BEACON 第二期临床试验中进行评估，针对的是尽管曾接受过筛窦手术但仍有复发症状的患者。
公司简介
公司代码LYRA
公司名称Lyra Therapeutics Inc
上市日期May 01, 2020
成立日期2005
CEODr. Maria Palasis, Ph.D.
员工数量30
证券类型Ordinary Share
年结日May 01
公司地址480 Arsenal Way
城市WATERTOWN
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编02472
电话16173734600
网址https://lyratherapeutics.com/
公司代码LYRA
上市日期May 01, 2020
成立日期2005
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Harlan W. Waksal, M.D.
Dr. Harlan W. Waksal, M.D.
Executive Chair and Chairperson of the Board
Executive Chair and Chairperson of the Board
10.74K
--
Dr. Nancy L. Snyderman, M.D.
Dr. Nancy L. Snyderman, M.D.
Independent Director
Independent Director
--
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Dr. Richard Nieman, M.D.
Dr. Richard Nieman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. James R (Jim) Tobin
Mr. James R (Jim) Tobin
Lead Independent Director
Lead Independent Director
--
--
Ms. C. Ann Merrifield
Ms. C. Ann Merrifield
Independent Director
Independent Director
--
--
Mr. W. Bradford Smith
Mr. W. Bradford Smith
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Harlan W. Waksal, M.D.
Dr. Harlan W. Waksal, M.D.
Executive Chair and Chairperson of the Board
Executive Chair and Chairperson of the Board
10.74K
--
Dr. Nancy L. Snyderman, M.D.
Dr. Nancy L. Snyderman, M.D.
Independent Director
Independent Director
--
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Dr. Richard Nieman, M.D.
Dr. Richard Nieman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. James R (Jim) Tobin
Mr. James R (Jim) Tobin
Lead Independent Director
Lead Independent Director
--
--
Ms. C. Ann Merrifield
Ms. C. Ann Merrifield
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
股东统计
占比
Perceptive Advisors LLC
19.25%
North Bridge Venture Partners
8.89%
BlackRock Institutional Trust Company, N.A.
4.53%
The Vanguard Group, Inc.
2.66%
Samsara BioCapital, LLC
2.10%
Other
62.57%
持股股东
股东统计
占比
Perceptive Advisors LLC
19.25%
North Bridge Venture Partners
8.89%
BlackRock Institutional Trust Company, N.A.
4.53%
The Vanguard Group, Inc.
2.66%
Samsara BioCapital, LLC
2.10%
Other
62.57%
股东类型
股东统计
占比
Private Equity
19.25%
Venture Capital
10.98%
Investment Advisor
6.77%
Investment Advisor/Hedge Fund
6.14%
Hedge Fund
4.27%
Research Firm
0.88%
Individual Investor
0.83%
Pension Fund
0.24%
Bank and Trust
0.08%
Other
50.56%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
166
33.99M
51.29%
-25.72M
2024Q4
169
34.27M
52.36%
-23.86M
2024Q3
170
41.74M
67.36%
-17.33M
2024Q2
155
41.35M
70.46%
-15.27M
2024Q1
137
54.47M
94.92%
+4.29M
2023Q4
113
50.90M
93.69%
+8.93M
2023Q3
96
40.42M
84.31%
-314.10K
2023Q2
103
42.33M
88.17%
+11.26M
2023Q1
124
25.98M
81.63%
-890.12K
2022Q4
126
26.32M
82.72%
+975.89K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Perceptive Advisors LLC
12.76M
19.36%
--
--
Dec 31, 2024
North Bridge Venture Partners
5.89M
8.94%
--
--
Feb 28, 2025
BlackRock Institutional Trust Company, N.A.
3.08M
4.68%
+98.60K
+3.31%
Dec 31, 2024
The Vanguard Group, Inc.
1.79M
2.71%
+8.16K
+0.46%
Dec 31, 2024
Samsara BioCapital, LLC
1.97M
2.98%
-814.57K
-29.30%
Dec 31, 2024
Ikarian Capital LLC
1.06M
1.61%
+1.32K
+0.12%
Dec 31, 2024
Geode Capital Management, L.L.C.
885.97K
1.34%
+117.58K
+15.30%
Dec 31, 2024
Nantahala Capital Management, LLC
628.07K
0.95%
+628.07K
--
Sep 30, 2024
Two Sigma Investments, LP
595.50K
0.9%
-147.35K
-19.84%
Dec 31, 2024
Waksal (Harlan W)
536.97K
0.82%
+275.00K
+104.98%
Feb 28, 2025
查看更多
持股ETF
更新时间: 5 小时前
更新时间: 5 小时前
机构名称
占比
ProShares Hedge Replication ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
查看更多
ProShares Hedge Replication ETF
占比0%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
iShares Russell 2000 ETF
占比0%
iShares Micro-Cap ETF
占比0%
Global X Russell 2000 ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Proshares Ultra Russell 2000
占比0%
Avantis US Small Cap Equity ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
